Mavik and Itching - a phase IV clinical study of FDA data

Summary:

Itching is reported as a side effect among people who take Mavik (trandolapril), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Zantac, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Itching when taking Mavik. It is created by eHealthMe based on reports of 3,071 people who have side effects when taking Mavik from the FDA, and is updated regularly.

What is Mavik?

Mavik has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 3,145 Mavik users. Check the latest studies of Mavik.

What is Itching?

Itching is found to be associated with 3,210 drugs and 4,535 conditions by eHealthMe. Check the latest studies of Itching.

On Jul, 09, 2026

3,071 people reported to have side effects when taking Mavik.
Among them, 63 people (2.05%) have Itching.

Among these 63 people:

How long have people been on Mavik when they have Itching? *

What is the gender of people who have Itching when taking Mavik? *

female: 77.19 %
male: 22.81 %

What is the age of people who have Itching when taking Mavik? *

What are other drugs people take besides Mavik? *

What are other side effects people have besides Itching? *

Rashes (redness): 30 people, 47.62%
Skin Plaque (red, scaly patches to appear on the skin): 22 people, 34.92%
Dyspnea (difficult or laboured breathing): 18 people, 28.57%
Pneumonia: 16 people, 25.40%
Headache (pain in head): 16 people, 25.40%
Urticaria (rash of round, red welts on the skin that itch intensely): 16 people, 25.40%
Fatigue (feeling of tiredness): 15 people, 23.81%
Angioedema (rapid swelling of the dermis): 14 people, 22.22%
Cough: 13 people, 20.63%
Face Oedema (swelling of face): 13 people, 20.63%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 17.46%
Quit Smoking: 6 people, 9.52%
Immunodeficiency Disorders: 5 people, 7.94%
Pain: 5 people, 7.94%
Carcinoid Tumor: 4 people, 6.35%
Rashes (redness): 4 people, 6.35%
Diabetes: 4 people, 6.35%
Depression: 3 people, 4.76%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 2 people, 3.17%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 3.17%

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and have Itching?

- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mavik:

Mavik (3,145 reports)

Itching treatments and more:

Itching (398,821 reports)

Browse all side effects of Mavik:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Itching:

Itching (3,210 drugs)

Browse all the conditions that are associated with Itching:

Itching (4,535 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril (the active ingredients of Mavik) and Mavik (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.